Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Urology

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1659392

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1659392

Urolithiasis Management Devices

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Urolithiasis Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Urolithiasis Management Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Intracorporeal Lithotripsy Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 8.3% CAGR

The Urolithiasis Management Devices market in the U.S. is estimated at US$528.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.9 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Urolithiasis Management Devices Market - Key Trends & Drivers Summarized

What Are Urolithiasis Management Devices, and Why Are They So Crucial in Treating Kidney Stones?

Urolithiasis Management Devices are medical tools and equipment used to diagnose, manage, and treat urolithiasis, which is the formation of stones in the urinary system, including the kidneys, ureters, bladder, and urethra. Urolithiasis, commonly known as kidney stones, can cause severe pain, urinary blockages, and potential kidney damage if left untreated. These devices encompass a range of technologies, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents, which are designed to break down, remove, or facilitate the passage of kidney stones from the urinary tract. The devices allow for both non-invasive and minimally invasive treatment options, improving patient outcomes and reducing recovery times.

The importance of urolithiasis management devices lies in their ability to address a prevalent health condition that affects millions of individuals worldwide. Factors like dietary habits, dehydration, obesity, and certain medical conditions contribute to the development of kidney stones, making effective management crucial for maintaining renal health. Early diagnosis and timely treatment are essential to prevent complications such as infection, renal failure, and recurrent stone formation. Urolithiasis management devices provide healthcare professionals with tools to tailor treatment plans based on stone size, composition, and location, offering a patient-centric approach to kidney stone management. As the incidence of urolithiasis continues to rise globally, these devices play a critical role in ensuring effective, safe, and efficient treatment.

How Are Technological Advancements Shaping the Urolithiasis Management Devices Market?

Technological advancements have significantly enhanced the precision, efficacy, and safety of Urolithiasis Management Devices, driving innovation in kidney stone treatment. One of the most notable developments is the improvement in Extracorporeal Shock Wave Lithotripsy (ESWL), a non-invasive technique that uses focused shock waves to break kidney stones into smaller fragments that can be passed naturally. Modern ESWL devices are equipped with real-time imaging, improved stone localization, and patient positioning features, leading to higher success rates, reduced treatment times, and greater patient comfort. Additionally, advancements in electromagnetic and piezoelectric lithotripters have increased the precision and energy delivery of ESWL devices, enhancing stone fragmentation efficiency.

In minimally invasive procedures, ureteroscopes and nephroscopes have seen significant advancements in design, flexibility, and imaging capabilities. The development of digital ureteroscopes, which offer high-definition visualization, has improved the detection, targeting, and removal of stones in the urinary tract. Miniaturized and flexible ureteroscopes enable access to difficult-to-reach stones while minimizing trauma to surrounding tissues, reducing recovery times. Laser lithotripsy has also evolved, with innovations such as the use of holmium laser systems that offer high pulse rates, adjustable pulse widths, and dual-wavelength technology. These advancements allow for more efficient stone fragmentation, particularly in harder or larger stones, and provide better control over the procedure, enhancing safety.

Another key advancement is in the use of robotic-assisted surgical tools for complex cases of kidney stone removal. Robotic technologies offer greater precision, control, and dexterity, improving outcomes in percutaneous nephrolithotomy (PCNL) and other invasive procedures. Additionally, improved stent designs, such as drug-eluting and biodegradable stents, help in managing post-operative care, reducing complications like ureteral obstruction and infection. These technological innovations not only expand the capabilities of urolithiasis management devices but also align with broader trends toward minimally invasive, patient-friendly treatments that reduce hospital stays and healthcare costs.

What Are the Emerging Applications of Urolithiasis Management Devices Across Different Healthcare Settings?

Urolithiasis Management Devices are finding expanding applications across various healthcare settings, driven by the increasing prevalence of kidney stones and advancements in treatment modalities. In hospitals and specialized urology centers, these devices are widely used for both diagnostic and therapeutic purposes, supporting procedures like ESWL, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Urologists rely on advanced imaging and laser systems to ensure accurate stone localization, effective fragmentation, and complete removal, improving patient outcomes and reducing recurrence rates. These devices are also critical in outpatient surgical centers, where minimally invasive procedures are often performed to treat smaller stones, allowing for same-day discharge and faster recovery.

In emergency care settings, handheld ultrasound devices and portable imaging tools are becoming essential for rapid diagnosis and assessment of acute urolithiasis cases, enabling quick decision-making for appropriate treatment. Telemedicine platforms are also integrating diagnostic capabilities with remote consultation for initial assessment and follow-up care, supporting broader access to urolithiasis management. In primary care and clinics, non-invasive diagnostic tools like ultrasound and advanced urine analysis kits are used to detect stone formation early, facilitating timely referral to specialists and reducing the need for emergency interventions. Additionally, in-home care settings, wearable sensors and digital health apps are being used to monitor hydration, dietary intake, and potential stone symptoms, helping patients manage urolithiasis proactively. As healthcare becomes more decentralized and patient-centric, the applications of urolithiasis management devices are expanding, reflecting their versatility in addressing diverse healthcare needs across different care settings.

What Drives Growth in the Urolithiasis Management Devices Market?

The growth in the Urolithiasis Management Devices market is driven by several factors, including the rising prevalence of kidney stones, increasing adoption of minimally invasive treatments, and advancements in diagnostic and therapeutic technologies. One of the primary growth drivers is the global rise in urolithiasis cases, fueled by lifestyle factors such as poor hydration, high-sodium diets, obesity, and metabolic conditions like diabetes and hypertension. As the incidence of kidney stones increases, the demand for effective and timely management solutions has surged, making urolithiasis management devices essential tools for healthcare providers. The growing awareness of minimally invasive procedures, such as ESWL, ureteroscopy, and laser lithotripsy, has further driven the adoption of these devices, as patients and providers prefer treatments that offer faster recovery, reduced pain, and lower complication rates.

Advancements in imaging and laser technologies have also played a significant role in the market’s growth. The development of high-definition digital ureteroscopes, advanced lithotripters, and AI-driven diagnostic tools has improved the accuracy, safety, and efficiency of kidney stone treatment, leading to better patient outcomes. Additionally, the integration of AI and machine learning in imaging and diagnostics is enhancing stone detection, characterization, and treatment planning, making urolithiasis management more precise and personalized. Government initiatives and healthcare policies that promote better urological care, increased healthcare access, and awareness campaigns about kidney stone prevention and management have further supported market growth.

The rise of outpatient surgical centers and ambulatory care facilities has also contributed to the growth of the urolithiasis management devices market. These settings offer cost-effective and efficient treatments, increasing patient access to minimally invasive procedures. The expansion of telehealth and digital health tools for remote monitoring, dietary guidance, and post-treatment care has made urolithiasis management more comprehensive, supporting patients in managing their condition proactively. As healthcare systems continue to prioritize patient-centered care and advanced medical technologies, the demand for urolithiasis management devices is expected to grow, driven by innovations in treatment, increasing healthcare awareness, and the global focus on improving urological outcomes.

SCOPE OF STUDY:

The report analyzes the Urolithiasis Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types); End-Use (Hospitals & Clinics, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH
Show more
Product Code: MCP23002

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Urolithiasis Management Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Kidney Stones Drives Demand for Urolithiasis Management Devices
    • Growing Preference for Non-Surgical Treatments Sets the Stage for Device Adoption
    • Integration of Laser Technologies in Treatment Drives Urolithiasis Device Market
    • Expanding Role of Extracorporeal Shock Wave Lithotripsy (ESWL) Boosts Market Demand
    • Increasing Adoption of Ultrasound Imaging Drives Urolithiasis Treatment Solutions
    • Push for Single-Use Devices to Prevent Infections Boosts Device Adoption
    • Case Overview: Growth in Urology Clinics Enhances Demand for Urolithiasis Devices
    • Growing Use of Robotics in Stone Management Sets the Stage for Device Adoption
    • Focus on Outpatient Stone Treatment Enhances Market Opportunities
    • Increasing Prevalence of Obesity Propels Urolithiasis Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Intracorporeal Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Urolithiasis Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!